Virus Filtration Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Virus Filtration Market to 2025 - Global Analysis and Forecasts By Product (Filtration Systems, Kits & Reagents, Services, and Others), Application (Biologics, Medical Devices, Water Purification, and Air Purification), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Medical Device Companies, and Academic Research Institutes) and Geography

Publication Month: Sep 2018 | Report Code: TIPHE100001427 | No. of Pages: 150 | Category: Biotechnology | Status: Published

The global virus filtration market is expected to reach US$ 5,555.4 Mn in 2025 from US$ 2,139.4 Mn in 2017. The market is estimated to grow with a CAGR of 13.0% from 2018-2025.

Virus filtration market is segmented into product, application, and end user. On the basis of product, the market is segmented into filtration systems, kits & reagents, services and others. The market based on the application is segmented into biologics, medical devices, water purification, and air purification. On the basis of end user, the global virus filtration market is segmented into pharmaceutical & biotechnology companies, contract research organizations, medical device companies, and academic research institutes.


Virus filtration is a robust and effective virus clearance technology that is common unit operation in the manufacture of biologics. Some biological therapeutic products are produced using mammalian cell lines or human plasma. The risk of contamination with either known or unknown viruses in these products has been demonstrated; hence, regulatory agencies have mandated that manufacturers evaluate the risks of virus contamination and take necessary measures to mitigate these risks. Key factors driving the market are rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D and outsourcing activities are key drivers for the growth of the market. The report would be of an interest to various stakeholders operating in the virus filtration market. These stakeholders include healthcare institutes, contract research organizations (CROs), research institutes, virus filtration product manufacturers and vendors, research consulting firms, virus filtration service providers, distributors and others.

The objective of the study is to describe, define, and forecast the virus filtration market by product, application, end user, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall virus filtration market.

The report analyzes factors affecting market from both demand and supply side and further evaluates virus filtration market dynamics effecting the virus filtration market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.

The major players operating in the market include Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., Danaher (Pall Corporation), General Electric, Lonza, Charles River, Asahi Kasei Medical Co., Ltd., Wuxi AppTec, and Clean Cells among others. The company players are indulged into development of novel and innovative products to cater the demands of users in the virus filtration market. For instance, in June 2016, Sartorius Stedim Biotech (SSB), a sub-division of Sartorius AG introduced a new virus-retentive filter to be used in the cell culture media. The new filter provides the highest level of safety for customers’ upstream processes. This launch is expected to compliment and increase the bioprocess portfolio of Sartorius.

TABLE OF CONTENTS

1. INTRODUCTION 23
1.1 SCOPE OF THE STUDY 23
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 23

2. GLOBAL VIRUS FILTRATION MARKET – KEY TAKEAWAYS 24

3. GLOBAL VIRUS FILTRATION MARKET – MARKET LANDSCAPE 26
3.1 OVERVIEW 26
3.2 MARKET SEGMENTATION 26
3.2.1 Global Virus Filtration Market – By Product 27
3.2.2 Global Virus Filtration Market – By Application 28
3.2.3 Global Virus Filtration Market – By End User 28
3.2.4 Global Virus Filtration Market – By Geography 28
3.3 PEST ANALYSIS 29
3.3.1 North America – PEST Analysis 29
3.3.2 Europe– PEST Analysis 31
3.3.3 Asia Pacific – PEST Analysis 33
3.3.4 Middle East And Africa– PEST Analysis 35
3.3.5 South and Central America – PEST Analysis 37

4. GLOBAL VIRUS FILTRATION MARKET – KEY MARKET DYNAMICS 39
4.1 KEY MARKET DRIVERS 39
4.1.1 Rapid Growth of Pharmaceutical and Biotechnology Industry 39
4.1.2 Increasing Investments in R&D and Outsourcing Activities 40
4.1.3 Stringent Regulatory Framework 41
4.2 KEY MARKET RESTRAINTS 41
4.2.1 High Consolidation in the Market 41
4.2.2 Availability of Alternative Techniques for Viral Clearance 42
4.3 KEY MARKET OPPORTUNITIES 42
4.3.1 Growth of Pharmaceutical & Medical Device Research Outsourcing 42
4.3.2 High Market Potential In Emerging Economies 42
4.4 FUTURE TRENDS 43
4.4.1 Rapid Adoption of Single Use Technologies 43
4.5 IMPACT ANALYSIS 44

5. VIRUS FILTRATION MARKET – GLOBAL ANALYSIS 45
5.1 GLOBAL VIRUS FILTRATION MARKET REVENUE FORECASTS AND ANALYSIS 45
5.2 GLOBAL VIRUS FILTRATION MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 46
5.3 MARKET POSITIONING 47
5.4 PERFORMANCE OF KEY PLAYERS 47
5.4.1 Merck KGaA 47
5.4.2 Sartorius AG 48
5.5 EXPERT OPINIONS 48

6. VIRUS FILTRATION MARKET ANALYSIS– BY PRODUCT 49
6.1 OVERVIEW 49
6.2 KITS AND REAGENTS MARKET 50
6.2.1.1 Overview 50
6.2.1.2 Global Kits and Reagents Market Revenue and Forecasts to 2025 (US$ Mn) 50
6.3 FILTRATION SYSTEMS MARKET 51
6.3.1 Overview 51
6.3.2 Global Filtration Systems Market Revenue and Forecasts to 2025 (US$ Mn) 52
6.4 SERVICES MARKET 52
6.4.1.1 Overview 52
6.4.1.2 Global Services Market Revenue and Forecasts to 2025 (US$ Mn) 53
6.5 OTHERS MARKET 53
6.5.1.1 Overview 53
6.5.1.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 54

7. GLOBAL VIRUS FILTRATION MARKET ANALYSIS– BY APPLICATION 55
7.1 OVERVIEW 55
7.2 BIOLOGICS MARKET 56
7.2.1 Overview 56
7.2.2 Global Biologics Market Revenue and Forecasts to 2025 (US$ Mn) 56
7.2.3 Vaccines and Therapeutics Market 57
7.2.3.1 Overview 57
7.2.3.2 Global Vaccines and Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn) 57
7.2.4 Blood and Blood Products Market 58
7.2.4.1 Overview 58
7.2.4.2 Global Blood and Blood Products Market Revenue and Forecasts to 2025 (US$ Mn) 58
7.2.5 Cellular and Gene Therapy Products Market 59
7.2.5.1 Overview 59
7.2.5.2 Global Cellular and Gene Therapy Products Market Revenue and Forecasts to 2025 (US$ Mn) 59
7.2.6 Others Market 60
7.2.6.1 Overview 60
7.2.6.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn) 60
7.3 WATER PURIFICATION MARKET 61
7.3.1 Overview 61
7.3.2 Global Water Purification Market Revenue and Forecasts to 2025 (US$ Mn) 61
7.4 AIR PURIFICATION MARKET 62
7.4.1 Overview 62
7.4.2 Global Air Purification Market Revenue and Forecasts to 2025 (US$ Mn) 62

8. GLOBAL VIRUS FILTRATION MARKET ANALYSIS– BY END USER 63
8.1 OVERVIEW 63
8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 64
8.2.1 Overview 64
8.2.2 Global Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn) 64
8.3 CONTRACT RESEARCH ORGANIZATIONS MARKET 65
8.3.1 Overview 65
8.3.2 Global Contract Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn) 66
8.4 MEDICAL DEVICE COMPANIES MARKET 67
8.4.1 Overview 67
8.4.2 Global Medical Device Companies Market Revenue and Forecasts to 2025 (US$ Mn) 67
8.5 ACADEMIC & RESEARCH INSTITUTES MARKET 68
8.5.1 Overview 68
8.5.2 Global Academic & Research Institutes Market Revenue and Forecasts to 2025 (US$ Mn) 68

9. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 69
9.1 OVERVIEW 69
9.2 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.3 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 70
9.4 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 71
9.4.1 North America Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 71
9.5 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
9.6 NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 72
9.7 US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
9.7.1 US Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 73
9.7.2 US Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 74
9.7.3 US Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 74
9.7.3.1 US Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 74
9.7.4 US Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 75
9.8 CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 76
9.8.1 Canada Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 77
9.8.2 Canada Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 77
9.8.3 Canada Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 78
9.8.3.1 Canada Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 78
9.8.4 Canada Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 78
9.9 MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
9.9.1 Mexico Virus filtration Market Revenue and Forecasts to 2025 (US$ Mn) 79
9.9.2 Mexico Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 80
9.9.3 Mexico Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 80
9.9.3.1 Mexico Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 80
9.9.4 Mexico Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 81

10. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 82
10.1 OVERVIEW 82
10.2 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
10.3 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 83
10.4 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
10.4.1 Europe Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 84
10.5 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 84
10.6 EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 85
10.7 GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
10.7.1 Germany Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 86
10.7.2 Germany Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 87
10.7.3 Germany Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 87
10.7.3.1 Germany Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 87
10.7.4 Germany Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 88
10.8 UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
10.8.1 UK Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 89
10.8.2 UK Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 90
10.8.3 UK Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 90
10.8.3.1 UK Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 90
10.8.4 UK Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 91
10.9 FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
10.9.1 France Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 92
10.9.2 France Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 93
10.9.3 France Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 93
10.9.3.1 France Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 93
10.9.4 France Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 94

11. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 95
11.1 OVERVIEW 95
11.2 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
11.3 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
11.4 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
11.4.1 Asia Pacific Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 97
11.5 ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
11.6 ASIA PACIFIC VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 98
11.7 CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
11.7.1 China Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 99
11.7.2 China Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 100
11.7.3 China Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 100
11.7.3.1 China Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 100
11.7.4 China Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 101
11.8 JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 102
11.8.1 Japan Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 102
11.8.2 Japan Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 103
11.8.3 Japan Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 103
11.8.3.1 Japan Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 103
11.8.4 Japan Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 104
11.9 INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 105
11.9.1 India Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 106
11.9.2 India Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 106
11.9.3 India Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 107
11.9.3.1 India Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 107
11.9.4 India Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 107

12. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 108
12.1 OVERVIEW 108
12.2 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109
12.3 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 109
12.4 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 110
12.4.1 Middle East and Africa Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 110
12.5 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 111
12.6 MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 111
12.7 UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 112
12.8 UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 112
12.8.1 UAE Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 113
12.8.2 UAE Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 113
12.8.2.1 UAE Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 113
12.8.3 UAE Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 114
12.9 SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 115
12.10 SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 115
12.10.1 Saudi Arabia Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 116
12.10.2 Saudi Arabia Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 116
12.10.2.1 Saudi Arabia Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 116
12.10.3 Saudi Arabia Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 117
12.11 SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 118
12.12 SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 118
12.12.1 South Africa Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 119
12.12.2 South Africa Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 119
12.12.2.1 South Africa Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 119
12.12.3 South Africa Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 120

13. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 121
13.1 OVERVIEW 121
13.2 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 122
13.3 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 122
13.4 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 123
13.4.1 South and Central America Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 123
13.5 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 124
13.6 SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 124
13.7 BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 125
13.7.1 Brazil Virus Filtration Market Revenue and Forecasts to 2025 (US$ Mn) 125
13.7.2 Brazil Virus Filtration Market Revenue And Forecasts to 2025, By Product (US$ Mn) 126
13.7.3 Brazil Virus Filtration Market Revenue And Forecasts to 2025, By Application (US$ Mn) 126
13.7.3.1 Brazil Biologics Market Revenue And Forecasts to 2025, By Type (US$ Mn) 126
13.7.4 Brazil Virus Filtration Market Revenue And Forecasts to 2025, By End User (US$ Mn) 127

14. VIRUS FILTRATION MARKET –INDUSTRY LANDSCAPE 128
14.1 OVERVIEW 128
14.2 GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 128
14.3 ORGANIC DEVELOPMENTS 128
14.3.1 Overview 128
14.4 ORGANIC GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 129
14.5 PRODUCT LAUNCH 129
14.5.1 Recent Product Launches By Players In The Virus filtration Market 129
14.6 EXPANSION 130
14.6.1 Expansion In The Virus Filtration Market 130
14.7 INORGANIC DEVELOPMENTS 131
14.7.1 Overview 131
14.8 INORGANIC GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 131
14.9 ACQUISITION 131
14.9.1 Recent Acquisitions by Players in the Virus filtration Market 131
14.10 OTHERS 132
14.10.1 Other Organic Developments In The Virus filtration Market 132

15. VIRUS FILTRATION MARKET –KEY COMPANY PROFILES 133
15.1 MERCK KGAA 133
15.1.1 Key Facts 133
15.1.2 Business Description 133
15.1.3 Financial Overview 134
15.1.4 Product Portfolio 134
15.1.5 SWOT Analysis 135
15.1.6 Key Developments 135
15.2 SARTORIUS AG 136
15.2.1 Key Facts 136
15.2.2 Business Description 136
15.2.3 Financial Overview 137
15.2.4 Product Portfolio 137
15.2.5 SWOT Analysis 138
15.2.6 Key Developments 138
15.3 DANAHER (PALL CORPORATION) 140
15.3.1 Key Facts 140
15.3.2 Business Description 140
15.3.3 Financial Overview 141
15.3.4 Product Portfolio 141
15.3.5 SWOT Analysis 142
15.3.6 Key Developments 142
15.4 THERMO FISHER SCIENTIFIC INC. 143
15.4.1 Key Facts 143
15.4.2 Business Description 143
15.4.3 Financial Overview 144
15.4.4 Product Portfolio 144
15.4.5 SWOT Analysis 145
15.4.6 Key Developments 145
15.5 GENERAL ELECTRIC 146
15.5.1 Key Facts 146
15.5.2 Business Description 146
15.5.3 Financial Overview 147
15.5.4 Product portfolio 147
15.5.5 SWOT Analysis 149
15.5.6 KEY DEVELOPMENTS 149
15.6 CHARLES RIVER 150
15.6.1 Key Facts 150
15.6.2 Business Description 150
15.6.3 Financial Overview 151
15.6.4 Service Portfolio 151
15.6.5 Swot Analysis 151
15.6.6 Key Developments 152
15.7 WUXI APPTEC 153
15.7.1 Key Facts 153
15.7.2 Business Description 153
15.7.3 Financial Overview 153
15.7.4 Product Portfolio 153
15.7.5 SWOT Analysis 154
15.7.6 Key Developments 154
15.8 LONZA 155
15.8.1 Key Facts 155
15.8.2 Business Description 155
15.8.3 Financial Overview 156
15.8.4 Product/Service Portfolio 156
15.8.5 SWOT Analysis 156
15.8.6 Key Developments 157
15.9 ASAHI KASEI CORPORATION 158
15.9.1 Key Facts 158
15.9.2 Business Description 158
15.9.3 Financial Overview 159
15.9.4 Product Portfolio 159
15.9.5 SWOT Analysis 160
15.9.6 Key Developments 160
15.10 CLEAN CELLS 161
15.10.1 Key Facts 161
15.10.2 Business Description 161
15.10.3 Financial Overview 161
15.10.4 Product Portfolio 161
15.10.5 SWOT Analysis 162
15.10.6 Key Developments 162

16. APPENDIX 163
16.1 ABOUT THE INSIGHT PARTNERS 163
16.2 GLOSSARY OF TERMS 164
16.3 METHODOLOGY 166
16.3.1 Coverage 167
16.3.2 Secondary Research 168
16.3.3 Primary Research 168

LIST OF TABLES

TABLE 1. R&D INVESTMENTS BY MAJOR PHARMACEUTICAL COMPANIES 40
TABLE 2. R&D INVESTMENTS BY PHRMA MEMBER COMPANIES,2016 40
TABLE 3. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 70
TABLE 4. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 71
TABLE 5. NORTH AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 71
TABLE 6. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 72
TABLE 7. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 74
TABLE 8. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 74
TABLE 9. US BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 74
TABLE 10. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 75
TABLE 11. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 77
TABLE 12. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 78
TABLE 13. CANADA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 78
TABLE 14. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 78
TABLE 15. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 80
TABLE 16. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 80
TABLE 17. MEXICO BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 80
TABLE 18. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 81
TABLE 19. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 83
TABLE 20. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 84
TABLE 21. EUROPE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 84
TABLE 22. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 84
TABLE 23. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 87
TABLE 24. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 87
TABLE 25. GERMANY BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 87
TABLE 26. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 88
TABLE 27. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 90
TABLE 28. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 90
TABLE 29. UK BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 90
TABLE 30. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 91
TABLE 31. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 93
TABLE 32. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 93
TABLE 33. FRANCE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 93
TABLE 34. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 94
TABLE 35. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 96
TABLE 36. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 97
TABLE 37. ASIA PACIFIC BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 97
TABLE 38. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 97
TABLE 39. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 100
TABLE 40. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 100
TABLE 41. CHINA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 100
TABLE 42. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 101
TABLE 43. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 103
TABLE 44. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 103
TABLE 45. JAPAN BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 103
TABLE 46. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 104
TABLE 47. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 106
TABLE 48. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 107
TABLE 49. INDIA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 107
TABLE 50. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 107
TABLE 51. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 109
TABLE 52. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 110
TABLE 53. MIDDLE EAST AND AFRICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 110
TABLE 54. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 111
TABLE 55. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 111
TABLE 56. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 113
TABLE 57. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 113
TABLE 58. UAE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 113
TABLE 59. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 114
TABLE 60. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 116
TABLE 61. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 116
TABLE 62. SAUDI ARABIA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 116
TABLE 63. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 117
TABLE 64. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 119
TABLE 65. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 119
TABLE 66. SOUTH AFRICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 119
TABLE 67. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 120
TABLE 68. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 122
TABLE 69. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 123
TABLE 70. SOUTH AND CENTRAL AMERICA BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 123
TABLE 71. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 124
TABLE 72. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN) 126
TABLE 73. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN) 126
TABLE 74. BRAZIL BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 126
TABLE 75. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN) 127
TABLE 76. RECENT PRODUCT LAUNCHES IN THE VIRUS FILTRATION MARKET 129
TABLE 77. EXPANSION IN THE VIRUS FILTRATION MARKET 130
TABLE 78. RECENT ACQUISITIONS IN THE VIRUS FILTRATION MARKET 131
TABLE 79. OTHER ORGANIC DEVELOPMENTS IN THE VIRUS FILTRATION MARKET 132
TABLE 80. GLOSSARY OF TERMS, VIRUS FILTRATION MARKET 164

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC VIRUS FILTRATION MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 24
FIGURE 2. GLOBAL VIRUS FILTRATION MARKET BY PRODUCT, MARKET SHARE (%), 2017 24
FIGURE 3. GLOBAL VIRUS FILTRATION MARKET BY APPLICATION, MARKET SHARE (%), 2017 25
FIGURE 4. GLOBAL VIRUS FILTRATION MARKET BY END USER, MARKET SHARE (%), 2017 25
FIGURE 5. VIRUS FILTRATION MARKET SEGMENTATION 26
FIGURE 6. VIRUS FILTRATION SEGMENTATION, BY REGION 27
FIGURE 7. NORTH AMERICA PEST ANALYSIS 29
FIGURE 8. EUROPE PEST ANALYSIS 31
FIGURE 9. ASIA PACIFIC PEST ANALYSIS 33
FIGURE 10. MIDDLE EAST AND AFRICA PEST ANALYSIS 35
FIGURE 11. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 37
FIGURE 12. VIRUS FILTRATION MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 44
FIGURE 13. GLOBAL VIRUS FILTRATION MARKET – REVENUE FORECASTS AND ANALYSIS – 2016- 2025 45
FIGURE 14. GLOBAL VIRUS FILTRATION MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 46
FIGURE 15. GLOBAL VIRUS FILTARTION MARKET – KEY MARKET PLAYERS 47
FIGURE 16. GLOBAL VIRUS FILTRATION MARKET BREAKDOWN, BY PRODUCT 2017 & 2025 (%) 49
FIGURE 17. GLOBAL KITS AND REAGENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
FIGURE 18. GLOBAL FILTRATION SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 19. GLOBAL SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 53
FIGURE 20. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 21. GLOBAL VIRUS FILTRATION MARKET SHARE, BY APPLICATION 2017 & 2025 (%) 55
FIGURE 22. GLOBAL BIOLOGICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 56
FIGURE 23. GLOBAL VACCINES AND THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 24. GLOBAL BLOOD AND BLOOD PRODUCTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 58
FIGURE 25. GLOBAL CELLULAR AND GENE THERAPY PRODUCTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
FIGURE 26. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 27. GLOBAL WATER PURIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 28. GLOBAL AIR PURIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 62
FIGURE 29. GLOBAL VIRUS FILTRATION MARKET SHARE, BY END USER 2017 & 2025 (%) 63
FIGURE 30. GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 64
FIGURE 31. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
FIGURE 32. GLOBAL MEDICAL DEVICE COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 67
FIGURE 33. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
FIGURE 34. NORTH AMERICA VIRUS FILTRATION MARKET OVERVIEW, BY COUNTRY (2017) 69
FIGURE 35. NORTH AMERICA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 36. NORTH AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 72
FIGURE 37. US VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 38. CANADA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
FIGURE 39. MEXICO VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
FIGURE 40. EUROPE VIRUS FILTRATION MARKET OVERVIEW, BY COUNTRY (2017) 82
FIGURE 41. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 83
FIGURE 42. EUROPE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 85
FIGURE 43. GERMANY VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
FIGURE 44. UK VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 89
FIGURE 45. FRANCE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 92
FIGURE 46. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 95
FIGURE 47. ASIA PACIFIC VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 96
FIGURE 48. ASIA PACIFIC VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 98
FIGURE 49. CHINA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 99
FIGURE 50. JAPAN VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 102
FIGURE 51. INDIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 106
FIGURE 52. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 108
FIGURE 53. MIDDLE EAST AND AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 109
FIGURE 54. UAE VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 112
FIGURE 55. SAUDI ARABIA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 115
FIGURE 56. SOUTH AFRICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 118
FIGURE 57. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE, BY COUNTRY, 2017 (US$ MN) 121
FIGURE 58. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 122
FIGURE 59. SOUTH AND CENTRAL AMERICA VIRUS FILTRATION MARKET SHARE BY COUNTRY, 2017 AND 2025 (%) 124
FIGURE 60. BRAZIL VIRUS FILTRATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 125
FIGURE 61. GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 128
FIGURE 62. ORGANIC GROWTH STRATEGIES IN THE VIRUS FILTRATION MARKET, 2015-2018 129
FIGURE 63. INORGANIC DEVELOPMENTS IN THE VIRUS FILTRATION MARKET, 2015-2018 131
The List of Companies

1. Merck KGaA
2. Sartorius AG
3. Danaher (Pall Corporation)
4. Thermo Fisher Scientific, Inc.
5. General Electric
6. Charles River
7. Wuxi Apptec
8. Lonza
9. Asahi Kesai Corporation
10. Clean Cells





    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the virus filtration market.







    • Highlights key business priorities in order to assist companies to realign their business strategies.







    • The key findings and recommendations highlight crucial progressive industry trends in the global virus filtration market, thereby allowing players across the value chain to develop effective long-term strategies.







    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.







    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.







    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution


Select License Type
USD $4550
USD $6550
USD $8550